Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21,185Revenue (TTM) $M2,601Net Margin (%)19.8Altman Z-Score11.0
Enterprise Value $M20,835EPS (TTM) $2.3Operating Margin %25.9Piotroski F-Score6
P/E(ttm)42.7Beneish M-Score-2.1Pre-tax Margin (%)24.7Higher ROA y-yN
Price/Book9.410-y EBITDA Growth Rate %19.1Quick Ratio3.2Cash flow > EarningsY
Price/Sales8.45-y EBITDA Growth Rate %28.0Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow46.7y-y EBITDA Growth Rate %-44.6ROA % (ttm)13.6Higher Current Ratio y-yN
Dividend Yield %--PEG1.5ROE % (ttm)21.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M212ROIC % (ttm)31.5Gross Margin Increase y-yY

Gurus Latest Trades with EW

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EWVanguard Health Care Fund 2016-03-31 Sold Out -0.51%$74.52 - $89.56
($82.56)
$ 100.0421%Sold Out0
EWRon Baron 2016-03-31 Reduce-0.05%$74.52 - $89.56
($82.56)
$ 100.0421%Reduce -20.41%528,665
EWVanguard Health Care Fund 2015-12-31 Add0.14%$72.16 - $82.56
($78.04)
$ 100.0428%Add 36.80%3,217,520
EWRon Baron 2015-12-31 Add0.11%$72.16 - $82.56
($78.04)
$ 100.0428%Add 87.82%664,199
EWJoel Greenblatt 2015-12-31 Sold Out -0.01%$72.16 - $82.56
($78.04)
$ 100.0428%Sold Out0
EWVanguard Health Care Fund 2015-09-30 Reduce-0.3%$66.95 - $78.36
($72.32)
$ 100.0438%Reduce -30.88%4,704,120
EWJoel Greenblatt 2015-09-30 Reduce-0.12%$66.95 - $78.36
($72.32)
$ 100.0438%Reduce -92.99%15,554
EWRon Baron 2015-09-30 Reduce-0.01%$66.95 - $78.36
($72.32)
$ 100.0438%Reduce -6.81%707,254
EWJoel Greenblatt 2015-06-30 Reduce-0.14%$61.93 - $73.09
($67.76)
$ 100.0448%Reduce -54.07%221,828
EWRon Baron 2015-06-30 Reduce-0.1%$61.93 - $73.09
($67.76)
$ 100.0448%Reduce -33.54%758,932
EWJoel Greenblatt 2015-03-31 Reduce-0.01%$62.68 - $74.47
($67.2)
$ 100.0449%Reduce -2.59%482,934
EWRon Baron 2015-03-31 Reduce$62.68 - $74.47
($67.2)
$ 100.0449%Reduce -1.01%1,141,976
EWVanguard Health Care Fund 2014-12-31 Reduce-0.21%$49.02 - $66.74
($60.55)
$ 100.0465%Reduce -19.13%6,805,340
EWRon Baron 2014-12-31 Reduce-0.11%$49.02 - $66.74
($60.55)
$ 100.0465%Reduce -31.07%1,153,672
EWJoel Greenblatt 2014-12-31 Reduce-0.03%$49.02 - $66.74
($60.55)
$ 100.0465%Reduce -9.20%495,752
EWVanguard Health Care Fund 2014-09-30 Reduce-0.16%$42.22 - $52.01
($47.34)
$ 100.04111%Reduce -14.48%8,414,940
EWRon Baron 2014-09-30 Reduce-0.08%$42.22 - $52.01
($47.34)
$ 100.04111%Reduce -22.73%1,673,734
EWJoel Greenblatt 2014-09-30 Add0.01%$42.22 - $52.01
($47.34)
$ 100.04111%Add 5.37%545,988
EWJoel Greenblatt 2014-06-30 Add0.2%$36.49 - $43.93
($40.61)
$ 100.04146%Add 261.38%518,146
EWRon Baron 2014-06-30 Reduce-0.08%$36.49 - $43.93
($40.61)
$ 100.04146%Reduce -20.04%2,166,008
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EW is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EW: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LORANGER STEVEN RDirector 2016-05-24Buy5,000$101.07-1.02view
Verguet Patrick BCVP, Europe 2016-05-18Sell13,000$102.75-2.64view
MUSSALLEM MICHAEL AChairman & CEO 2016-05-05Sell59,000$104.12-3.92view
WANG HUIMINCVP, Japan & Intercontinental 2016-05-05Sell13,650$103.36-3.21view
Verguet Patrick BCVP, Europe 2016-05-02Sell7,000$106.86-6.38view
MUSSALLEM MICHAEL AChairman & CEO 2016-04-29Sell59,000$106.13-5.74view
WANG HUIMINCVP, Japan & Intercontinental 2016-04-05Sell13,650$103.97-3.78view
MUSSALLEM MICHAEL AChairman & CEO 2016-03-17Sell59,000$84.3918.54view
WANG HUIMINCVP, Japan & Intercontinental 2016-03-07Sell13,650$87.1714.76view
MUSSALLEM MICHAEL AChairman & CEO 2016-02-18Sell59,000$86.9415.07view

Press Releases about EW :

Quarterly/Annual Reports about EW:

News about EW:

Articles On GuruFocus.com
Vanguard Sells Out Edwards Lifesciences May 03 2016 
Sands Capital Boosts Stake in Edwards Lifesciences Mar 09 2016 
Frank Sands Acquires Stake in Netflix Feb 23 2016 
15 Best Stocks for Value Investors This Week Feb 15 2016 
Starbucks, Foot Locker Beat the Market Over Past Year Feb 10 2016 
Weekly 52-Week Highs Highlight: H&R Block, Edwards Lifesciences, Amazon.com, Chubb Nov 02 2015 
The Best Companies of the Medical Industry – September 2015 Sep 25 2015 
The Problem with Mechanical Investment Strategies and How You Can Find Your Own Ideas May 27 2015 
Vanguard Health Care Fund's Undervalued Stocks Apr 03 2015 
Fairly Valued Long-Term Performer – Edwards Lifesciences Mar 23 2015 

More From Other Websites
United Parcel Service Inc. (UPS) and EnerSys (ENS) Witness Insider Selling, While 3 Companies... May 27 2016
New Strong Buy Stocks for May 27th May 27 2016
3 Healthcare Stocks at All-Time Highs (ISRG, HSIC) May 25 2016
2 Momentum Health Care Stocks That Will Continue to Outpace the Industry May 25 2016
Edwards Lifesciences: Q1 Strong, TAVR Prospects Bright May 25 2016
Edwards Lifesciences Has a Faulty 'Ticker' May 24 2016
Edwards Lifesciences (EW) Stock Price Target Raised at Canaccord May 23 2016
Stocks End Week On High Note; Chips, Biotechs Power Nasdaq May 20 2016
ETF’s with exposure to Edwards Lifesciences Corp. : May 20, 2016 May 20 2016
S&P 500 to Celebrate One Year of New High: Top ETFs & Stocks May 20 2016
Jury Finds in Favor of CardiAQ in Case with Neovasc May 20 2016
Edwards Lifesciences Corp. breached its 50 day moving average in a Bearish Manner : EW-US : May 20,... May 20 2016
Jury Finds in Favor of CardiAQ in Case with Neovasc May 19 2016
'Mad Money' Lightning Round: Edwards Lifesciences Is Going Higher May 19 2016
Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European... May 18 2016
Edwards' Surgical Heart Valve Innovations Demonstrate Positive Patient Benefits May 18 2016
Edwards Lifesciences Presents Positive Data on Sapien3 May 18 2016
Edwards' Surgical Heart Valve Innovations Demonstrate Positive Patient Benefits May 17 2016
Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European... May 17 2016
Can Edwards Lifesciences (EW) Stock Continue to Grow Earnings? May 16 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)